Hyoscyamine-producing marine Actinomycetes from Lagos Lagoon sediment  by Flora, Davies Olabisi et al.
196
Document heading                                                                                   ©2015 by the Asian Pacific Journal of Tropical Biomedicine. All rights reserved.
Hyoscyamine-producing marine Actinomycetes from Lagos Lagoon sediment 
Davies Olabisi Flora1,2*, Adeleye Isaac Adeyemi1, Wang Peng George2
1Department of Microbiology, University of Lagos, Akoka, Lagos State, Nigeria
2Department of Chemistry, Georgia State University, Atlanta, Georgia, U.S.A
Asian Pac J Trop Biomed 2015; 5(3): 196-201
Asian Pacific Journal of Tropical Biomedicine
journal homepage: www.elsevier.com/locate/apjtb
Contents lists available at ScienceDirect
    *Corresponding author: Davies Olabisi Flora, Department of Microbiology, 
University of Lagos, Akoka, Lagos State, Nigeria.
      E-mail: bizdave1@gmail.com
      Tel: +1-(678)467-6311
    Foundation Project: Supported by University of Lagos Central Research 
Committee Grant (Grant No: 2012/08).
1. Introduction
   There is a continuous search for safe antimicrobial agents effective 
against clinical infections caused by Gram-negative organisms, 
fungi, viruses and mycobacteria. For many years, bioprospecting 
for novel secondary metabolites have focused on the terrestial 
environment but marine environment was largely overlooked[1,2]. 
This is probably because scientists imagined that seawater contained 
very few microorganisms due to its extreme salinity which is 
deemed to be unfavourable habitat for many microorganisms. That 
impression has thus been changed as researchers have hypothesized 
that since conditions in both marine and terrestial ecosystem are 
extremely different,  the microorganisms in the marine environment 
should possess characteristics different from those in the terrestial 
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Objective: To isolate and screen Actinomycetes from Lagos Lagoon soil sediments for 
production of  bioactive metabolites.
Methods: Sediment samples were collected from four different locations of Lagos Lagoon 
and were dried for 2 weeks after which the Actinomycetes were isolated by serial dilution 
using the spread plate method on starch casein and Kuster’s agar supplemented with 80 μg/
mL cycloheximide to prevent fungal growth. The plates were incubated at 28 °C for 1-2 weeks. 
Isolates were selected based on their colonial characteristics as well as their Gram’s reaction 
and subcultured using the same media for isolation until pure cultures were obtained and 
incubated at 28 °C for 3 d. Thereafter, they were inoculated into starch casein and Kuster’s 
broth media and incubated for 8 d. The secondary metabolites were screened for antimicrobial 
activity against the following microorganisms: methicillin resistant Staphylococcus aureus, 
Staphylococcus aureus ATCC 29213, Escherichia coli ATCC 29522, Pseudomonas aeruginosa 
ATCC 27853, Candida albicans and Enterococcus faecalis ATCC 29212. Coagulase-
negative staphylococci isolated from HIV patients were also used (Staphylococcus warneri, 
Staphylococcus xylosus and Staphylococcus epidermidis). The antimicrobial metabolites of the 
Actinomycetes isolates were identified using gas chromatography (GC).
Results: Crude extracts of isolates showed antimicrobial activity against some of the test 
organisms. The GC data analysis showed the antibiotic profile of these isolates. 
Conclusions: Analysis of the crude extracts of the isolates using GC method, revealed the 
presence of antibiotics including an anticholinergic hyoscyamine among other conclusions.
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ecosystem and therefore would have the tendency to produce 
different bioactive compounds[3,4]. Recent discoveries from marine 
bacteria include Neopyrrolomycins, Salinosporamycin as well as 
Salinosporamide which have shown high microbial and antitumor 
activity.
   Most known antibiotics are produced by Actinomycetes which 
are Gram-positive filamentous bacteria, which are abundant in soil, 
water and plants[5]. The evaluation of antibiotic-producing potential 
of new and less known Actinomycetes from new or underexplored 
ecosystems is therefore important in the discovery of novel 
therapeutic agents for use against drug-resistant microorganisms 
and treatment of diseases. To combat the problem of resistant 
microorganisms to available antibiotics, there is a need for periodic 
replacement of existing antibiotics with novel antibiotics through 
screening of unexplored habitats.
   Hyoscamine is a tropane alkaloid which is a bio-active compound 
with therapeutic importance such as treatment of Parkinson’s 
disease[6,7], and it has been reported to have analgesic, antispasmodic 
and sedative properties[8]. It is synthesized mainly by plants 
belonging to the family Solanaceae such as Hyoscyamus muticus and 
Datura stramonium L. and only few reports of its presence in crude 
extracts of Actinomycetes are available but none from African marine 
environment[9,10]. 
   There is no evidence in literature that suggests that indigenous 
Actinomycetes of the marine environment in West Africa have been 
exploited for drug discovery. Therefore, this study was carried out to 
isolate and screen marine Actinomycetes from the unexplored Lagos 
Lagoon for drug discovery by possible novel strains. 
2. Materials and methods
2.1. Sample collection and isolation of Actinomycetes
   Sediment samples were collected from different locations of Lagos 
Lagoon using pre-sterilized grab. The samples were kept in sterile 
polythene bags and transported immediately to the laboratory. They 
were air-dried at ambient temperature for 2 weeks after which the 
Actinomycetes were isolated by serial dilution of 1 g of soil samples 
using spread plate method on starch casein and Kuster’s agar 
supplemented with 80 μg/mL of cycloheximide to prevent fungal 
growth[11]. The plates were incubated at 28 °C for 1-2 weeks. Gram-
positive bacteria were identified by Gram-staining and Actinomycetes 
were identified among Gram-positive isolates using morphological 
characteristics. Pure cultures were maintained on nutrient agar slants 
at 4 °C[12].
2.2. Biochemical characterization of isolates
   Biochemical studies were carried out on the suspected 
Actinomycetes isolates using the API 20A kit (Biomerieux, 
France). The tests were carried out according to the manufacturer’s 
instructions, incubated at 28 °C for 24-48 h and were later read. All 
the positive and negative tests were recorded. Other biochemical 
tests such as starch hydrolysis and casein hydrolysis were carried out 
using standard methods[13].
2.3. DNA extraction, amplification and sequencing
   DNA was extracted from the isolates using Qiagen DNA extraction 
kit (Qiagen, Germany) and stored at -20 °C. A ~640 bp fragment of 
the 16S rRNA gene of all strains was amplified by PCR using the 
actinobacteria-specific primers S-C-Act-0235-a-S-20 5’CGC GGC 
CTA TCA GCT TGG TTG 3’ and S-C-Act-0878-a-A-19 5’CCG 
TAC TCC CCA GGC GGG G3’[14]. PCR conditions consisted of an 
initial denaturation stage at 94 °C for 4 min, followed by 35 cycles 
of denaturation at 94 °C for 30 seconds, annealing at 60 °C for 45 
seconds, extension at 72 °C for 50 seconds and a final extension 
at 72 °C for 5 min. Negative controls with no DNA template were 
included in all PCR experiments. Amplification was detected by 
agarose gel electrophoresis and visualized by ultraviolet fluorescence 
after ethidium bromide staining[4]. PCR products were purified using 
a PCR purification kit (Qiagen, U.S.A) and were sequenced by an 
automated sequencer using the forward primer as above. Sequences 
were compared with sequences from reference species of bacteria 
contained in genomic database banks, using the NCBI BLAST 
search available at http://www.ncbinlm-nih.gov/.
2.4. Screening of secondary metabolites for antimicrobial 
activity
   A loopful of each pure actinomycete culture was inoculated into 
30 mL sterile starch casein as well as Kuster’s broth and incubated 
on a rotary shaker at 180 r/min for 8 d at 28 °C. The culture was 
later centrifuged at 5000 r/min for 20 min and cell-free supernatant 
was collected. Using the agar well diffusion method, agar plates 
were seeded with test strains adjusted to 0.5 MacFarland standard 
and 6 mm wells were bored in the agar plates using sterile cork 
borer and cell-free supernatant poured into the wells. The cell-
free supernatant was assayed for antimicrobial activity against the 
following microorganisms: methicillin resistant Staphylococcus 
aureus (S. aureus), S. aureus ATCC 29213, Escherichia coli ATCC 
29522, Pseudomonas aeruginosa ATCC 27853, Candida albicans 
(C. albicans) and Enterococcus faecalis ATCC 29212. Coagulase-
negative staphylococci (CoNS) isolated from HIV patients were 
also used (Staphylococcus warneri, Staphylococcus xylosus and 
Staphylococcus epidermidis). Sterile Mueller–Hinton and Sabouraud 
dextrose agar plates were seeded with test bacteria and yeast 
respectively. The plates seeded with bacteria were incubated at 37 °C 
for 24 h while those seeded with the yeast were incubated at 37 °C 
for 48 h after which zones of inhibition indicative of antimicrobial 
activity were assessed. 
2.5. Gas chromatography (GC) analysis of crude extract
   Identification of the secondary metabolites was carried out 
by GC analysis using the method of Khalvati et al. with some 
modifications[15]. Twenty millilitre of cell-free crude extract was 
mixed with a combination of ethyl acetate/methanol (1:1) in a 
separating funnel and shaken vigorously for 30 min and allowed to 
stand without any disturbance for 15 min. The organic phase was 
collected into a glass beaker and concentrated to 1 mL. A standard 
(pure) for the antibiotic combinations was first injected into the 
GC to set its equivalent peak area and retention time profiles of the 
individual antibiotics. Afterwards, 0.1 μL was injected in to GC 6890 
series (Hewlett Packard) using SE 30 column with specification 
(column size- 0.25 mm伊30 m, carrier gas- nitrogen, flow rate- 22 
mL/min, injection temperature- 220 °C, acceleration and reflector 
temperature- 10 °C/min, initial column temperature- 50 °C, holding 
time- 2 min). The peak of the standard antibiotics were compared to 
those of the test samples.
3. Results
   Three isolates (ULK2, ULK7 and ULS14) suspected to be 
Actinomycetes grew on the starch casein and Kuster’s agar 
suplemented with cycloheximide. The mycelia of ULK2 colonies 
were white leathery and turned creamy with age and produced brown 
pigment in agar while that of ULK7 were white leathery turning 
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grey with age and produced dark brown pigment (Figure 1). ULS14 
colonies were white leathery turning faint pink and produced brown 
pigment in agar.
Figure 1. Isolates (ULK2 and ULK7) showing mycelia and diffusible 
pigment.
Figure 2. Antibacterial activity of actinomycete ULS14 and ULK2 against 
methicillin-resistant S. aureus.
   The result of the physicochemical characteristics of the suspected 
Actinomycetes isolates is shown in Table 1. The organisms were non-
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Figure 3. Detection of antibiotics present in the crude extract of ULK2.
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sporulative and could not hydrolyse mannitol, salicin, arabinose, 
esculin, melezitose, sorbitol and rhamnose while all isolates showed 
ability to utilize glucose, glycerol and hydrolyse starch. All the 
isolates were found to be Gram positive and filamentous. 
   The 16S rRNA (640 bp) was sequenced and identities of the strains 
(ULK2, ULK7 and ULS14) were derived from closest matches in 
the BLAST search of GenBank sequences. The isolate ULK2 shared 
99% similarity with Streptomyces fulvissimus DSM 40593, while 
isolates ULS14 and ULK7 were found to share 99% similarity with 
Streptomyces bingchenggensis BCW-1 and Streptomyces albus 
J1074 respectively.
   Table 2 shows the result of the antimicrobial assay of cell free 
broth of the Actinomycetes on test organisms. ULK7 showed 
minimal activity against the CoNS. ULK2 displayed moderate 
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Figure 4. Detection of antibiotics present in the crude extract of ULS14.
Table 1
Physicochemical characteristics of the Actinomycetes isolates.
Isolates IND URE GLU MAN LAC SAC MAL SAL XYL ARA GEL ESC GLY CEL MNE MLZ RAF SOR RHA TRE CAT SPO GRM STA CAS
ULK2 - - + - + + + - - - - - + - + - + - - - + - + + -
ULS14 +/- - +/- - - - - - - - + - + - + - - - - - + - + + +
ULK7 - - + - + + + - + - - - + - - - - - - - - - + + -
IND: Indole, URE: Urease, GLU: Glucose, MAN: Mannitol, LAC: Lactose, SAC: Saccharose, MAL: Maltose, SAL: Salicin, XYL: Xylose, ARA: 
Arabinose, GEL: Gelatin, ESC: Esculin, GLY: Glycerol, CEL: Cellobiose, MNE: Mannose, MLZ: Melezitose, RAF: Raffinose, SOR: Sorbitol, RHA: 
Rhamnose, TRE: Trehalose, CAT: Catalase, SPO-Spores, GRA: Gram reaction, STA: Starch hydrolysis, CAS: Casein hydrolysis.
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activity against CoN Staphylococcus warneri, methicillin resistant 
S. aureus and C. albicans. ULS14 showed moderate activity against 
methicillin resistant S. aureus while ULK7 showed minimal activity 
against the CoNS (Figure 2). The isolate ULK2 was the only one 
found to display the antibacterial and antifungal activity against the 
test organisms.-
   Figures 3, 4 and 5 show the result of the GC analysis of the crude 
extracts. The ethyl acetate/methanol extracts of the isolates identified 
15 different types of antibiotics with varying number of peak 
values at different time intervals. Peaks indicating the presence of 
erythromycin, nystatin, oxytetracycline, tylosin, marinomycins A-D, 
chloramphenicol, glaciapyrroles, cycloheximide, amythiamicins, 
streptomycin, ipomicin, capuramycin, avilamycin, tubelactomicin 
and hyoscamine were detected in the crude extracts. All isolates were 
found to produce ipomicin, capuramycin, tylosin and hyoscamine. 
4. Discussion
   A large number of Actinomycetes have been isolated and screened 
largely from the underexplored marine environment for novel drug 
discovery. Many bioactive compounds have been discovered to be 
synthesized by these marine Actinomycetes. 
   The Actinomycetes isolates encountered in this study were all 
found to be Gram-positive and filamentous. This is similar to the 
Table 2
Antimicrobial activities of crude cell-free extract against pathogenic microorganisms.
Isolates Zone of inhibition (mm)
Staphylococcus warneri MRSA Staphylococcus 
xylosus
Staphylococcus
epidermidis
Pseudomonas aeruginosa 
ATCC 27853 
Escherichia coli 
ATCC 29522
Enterococcus 
faecalis
S. aureus 
ATCC 29213
C. albicans
ULK2 4 6 - - - - - - 7
ULS14 - 5 - - - - - 5 -
ULK7 3 - - - - - - - -
MRSA: methicillin-resistant S. aureus.
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findings of Singh et al. who also identified Actinomycetes based on 
Gram reaction and morphology[13].
   The PCR amplification of 16S rRNA gene was detected by agarose 
gel electrophoresis. The actinobacteria-specific primers designated 
S-C-Act-0235-a-S-20 and S-C-Act-0878-a-A-1, which are used 
to improve the detection and identification of actinobacteria[14], 
amplified 640 bp stretch of the 16S rRNA gene from all strains 
thereby confirming them as Actinomycetes.
   Only extracts of ULK2 and ULS14 were found to have moderate 
inhibitory activity against methicillin-resistant S. aureus and this 
could be attributed to the presence of amythiamicins which are 
quite effective against drug-resistant strains. Isolate ULK2 was also 
observed to have antifungal properties which is similar to a previous 
report of Ceylan et al[16].
   Hyoscyamine which is usually found in plants was identified in 
the crude extracts of all the isolates through GC. Its presence in the 
ethyl acetate/methanolic extract of all the isolates is suggestive of 
these Actinomycetes isolates as new sources of this tropane alkaloid. 
Christhudas et al. also reported similar findings in a study whereby 
hyoscyamine was isolated from methanolic extract of Streptomyces 
spp, an endophytic actinomycete isolated from Datura stramonium 
L[10].
   A significant number of unidentified peaks were present in the 
extracts with the highest (18 peaks) being found in ethyl acetate/
methanolic extract of ULS14. This development could be indicative 
of the presence of some novel antimicrobials in the extract and 
further study could help in the isolation, purification and structure 
elucidation of the unidentified bioactive compounds.
   This study has helped to highlight the significance of the marine 
Actinomycetes of the Lagos marine environment as a potential source 
of novel bioactive compounds.
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Comments 
Background
   Emergence and increase of drug-resistant pathogenic bacteria, 
fungi and parasites provides strong incentive to find and develop 
new anti microbial agents. Although much efforts have been put 
into finding new bioactive drug from Actinomycetes, the authors 
think that not enough works have been performed for marine 
Actinomycetes of Lagos Lagoon areas.
  
Research frontiers
   The authors found at least three Streptomyces strains isolated 
from Logos Lagoon area produce bioactive substances including 
erythromycin, nystatin, oxytetracycline, tylosin, marinomycins, 
chloramphenicol, glaciapyrroles, cycloheximide, amythiamicins, 
streptomycin, hyoscyamine and so on. New bioactive compounds 
are expected to be found in the crude extracts.
Innovations and breakthroughs
   The authors showed a potential of Lagos Lagoon areas as a 
collecting (hunting) area for microorganisms which produce useful 
bioactive compounds. 
Applications
   It is helpful in finding novel and useful bioactive compounds from 
microorganisms in the lagoon areas.    
Peer review
   The paper provides information that Lagos Lagoon areas in Nigeria 
can potentially be a rich source of microorganisms which produce 
useful bioactive compounds. We could expect that the marine 
Actinomycetes and other organisms in the areas would provide new 
drugs useful in treatment of patients with infection or other illness.
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